Egg Ingestion in Adults With Type 2 Diabetes

Completed · Not applicable

Conditions studied: Type 2 Diabetes

In brief

We propose a prospective, randomized, single-blind controlled crossover study to assess the effects of daily egg inclusion versus egg exclusion, on glycemic control, anthropometric measures, and overall diet quality in adults with Type 2 diabetes.

Key facts

Study ID

NCT02052037

Run by

Griffin Hospital

People needed

32

Starts

2014-01-01

Expected to finish

2015-11-01

Last updated by the study team

2017-11-06

Who can join

Age: 35 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• males age greater than 35 years;
• post-menopausal females not currently on hormone replacement therapy;
• non-smokers;
• clinical diagnosis of Type 2 diabetes mellitus for at least 1 year but no more than 5 years;
• 6.5% ≤ HbA1c ≤8.0% (5) BMI between 25 and 40 kg/m².

You may not qualify if…

• failure to meet inclusion criteria;
• anticipated inability to complete study protocol for any reason;
• current eating disorder;
• use of antihyperglycemic, lipid-lowering or antihypertensive medications unless stable on medication for at least 3 months;
• use of glucocorticoids, antineoplastic agents, psychoactive agents, or nutraceuticals;
• regular use of fiber supplements;
• restricted diets (i.e., vegetarian, vegan, gluten free);
• known allergy to eggs.

Where it is running

• Yale-Griffin Prevention Research Center — Derby, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.